Profile
| Metric | Value |
|---|---|
| Full Name | Revvity, Inc. |
| Ticker | NYSE: RVTY |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Country | United States |
| IPO | |
| Indexes | |
| Website | revvity.com |
| Employees | 11,000 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $104.43 | |
| Price, 1D Change | +2.67% | |
| Market Cap | $12B | |
| TTM Dividend Yield | 0.27% | |
| PE Ratio | 52.23 | |
| Beta | 1.13 | |
| Revenue | $3B | |
| Revenue, 1Y Change | +0.16% | |
| EPS | $2.41 | |
| EPS, 1Y Change | +353.72% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | $0.07 | |
| Next Ex-Dividend | $0.07 | |
| Last Split | 2:1 | |
| Next Split | N/A | N/A |
| Last Ticker Change | PKI | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| EPS | $2.41 | |
| EPS Estimate | $4.91 | |
| EPS Est. Change | +103.95% | |
| Revenue | $2.76B | |
| Revenue Estimate | $2.84B | |
| Revenue Est. Change | +3.18% | |
| Current Price | $104.43 | |
| Price Target | - | $115.00 |
| Price Tgt. Change | - | +10.12% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $4.56 | -$0.95 | -120.82% | |
| $4.85 | $2.41 | -50.37% | |
| $4.91 | N/A | +103.95% | |
| $5.30 | N/A | +119.96% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $2.73B | $2.75B | +0.67% | |
| $2.75B | $2.76B | +0.06% | |
| $2.84B | N/A | +3.18% | |
| $2.93B | N/A | +6.35% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| Price, 1Y | -10.30% | |
| Price, 3Y | -22.00% | |
| Market Cap, 1Y | -15.70% | |
| Market Cap, 3Y | -29.98% | |
| Revenue, 1Y | +0.16% | |
| Revenue, 3Y | -28.03% | |
| EPS, 1Y | +353.72% | |
| EPS, 3Y | -70.20% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| Current Price | $104.43 | |
| SMA 200 | $94.19 | |
| SMA 200 vs Price | -9.81% | |
| SMA 50 | $97.71 | |
| SMA 50 vs Price | -6.43% | |
| Beta | 1.13 | |
| ATR | $2.80 | |
| 14-Day RSI | 62.04 | |
| 10-Day Volatility | 30.71% | |
| 1-Year Volatility | 38.63% |
Dividends
| Metric | Date | Value |
|---|---|---|
| Last Paid | $0.07 | |
| Upcoming | $0.07 | |
| Dividend Yield | 0.27% | |
| Total Dividend | $0.28 | |
| Dividends Paid | $34.45M | |
| Payout Ratio | 12.17% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| Revenue | $2.76B | |
| EPS | $2.41 | |
| Gross Profit | $1.32B | |
| Gross Margin | 48.01% | |
| Operating Profit | $410.52M | |
| Operating Margin | -37.09% | |
| Net Income | $283.07M | |
| Net Margin | 10.27% | |
| EBITDA | $838.37M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| Debt To Equity | 0.43 | |
| Current Ratio | 3.60 | |
| Quick Ratio | 3.03 | |
| - | ||
| F-Score | 7 | |
| Altman Z-Score | 2.66 |
Valuations
| Metric | Date | Value |
|---|---|---|
| PE Ratio | 52.23 | |
| PS Ratio | 4.21 | |
| PB Ratio | 1.61 | |
| EV/EBITDA | 17.53 | |
| Enterprise Value | N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| Book Value | $7.67B | |
| Cash & Equivalents | $1.16B | |
| Total Assets | $12.39B | |
| Current Assets | $2.35B | |
| Total Liabilities | $4.73B | |
| Current Liabilities | $653.10M | |
| Total Debt | $3.33B | |
| Short Term Debt | $23.82M | |
| Accounts Payable | $167.46M |
Expenses
| Metric | Date | Value |
|---|---|---|
| Total Expenses | $2.47B | |
| Operating Expenses | $912.14M | |
| Cost Of Goods Sold | $1.43B | |
| SG&A | $0.00 | |
| D&A | $427.85M | |
| Interest Expense | $0.00 | |
| Income Tax | $33.06M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| CFO | $628.30M | |
| CFI | $776.16M | |
| CFF | -$1.13B | |
| Capex | $86.65M | |
| Free Cash Flow | $541.65M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Wells Fargo | → | |
| Barclays | → | |
| Goldman Sachs | ||
| Barclays | → | |
| Baird | → | |
| Guggenheim | ||
| Evercore ISI Group | → | |
| Barclays | → | |
| B of A Securities | → | |
| Stifel | → |
Analyst sentiment
Institutional ownership
Screeners with RVTY
Data Sources & References
- RVTY Official Website www.revvity.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/31791/000003179125000032/0000031791-25-000032-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/31791/000003179125000009/0000031791-25-000009-index.htm
- List of S&P 500 Companies www.spglobal.com/spdji/en/indices/equity/sp-500/#overview
- RVTY Profile on Yahoo Finance finance.yahoo.com/quote/RVTY
- RVTY Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rvty
FAQ
What is the ticker symbol for Revvity, Inc.?
The ticker symbol for Revvity, Inc. is NYSE:RVTY
Does Revvity, Inc. pay dividends?
Yes, Revvity, Inc. pays dividends. The last payment was $0.07, with an ex-dividend date on October 17, 2025
What sector is Revvity, Inc. in?
Revvity, Inc. is in the Healthcare sector
What industry is Revvity, Inc. in?
Revvity, Inc. is in the Diagnostics & Research industry
What country is Revvity, Inc. based in?
Revvity, Inc. is headquartered in United States
When did Revvity, Inc. go public?
Revvity, Inc. initial public offering (IPO) was on July 6, 1965
Is Revvity, Inc. in the S&P 500?
Yes, Revvity, Inc. is included in the S&P 500 index
Is Revvity, Inc. in the NASDAQ 100?
No, Revvity, Inc. is not included in the NASDAQ 100 index
Is Revvity, Inc. in the Dow Jones?
No, Revvity, Inc. is not included in the Dow Jones index
When was Revvity, Inc. last earnings report?
Revvity, Inc.'s most recent earnings report was on October 27, 2025
When does Revvity, Inc. report earnings?
The next expected earnings date for Revvity, Inc. is January 26, 2026